You are currently viewing Rymedi partners with Incora Health

Rymedi partners with Incora Health

Greenville, SC — August 6, 2024 — Rymedi and Incora Health announce their strategic partnership aimed at improving women’s health.  The Incora Health Earring, designed to monitor women’s whole health through their unique menstrual cycles, will leverage Rymedi’s blockchain-enabled patient and population health data platform to serve as a comprehensive digital patient and results management tool.  Rymedi’s patented technology separates PHI from PII, securely storing a permanent and auditable record of the collection and resulting process.

Lindsey Calcutt, PhD, the Co-Founder and CEO of Incora Health, expressed her enthusiasm for the partnership, saying, “We are thrilled to partner with Rymedi to leverage their cutting-edge blockchain technology. This collaboration will enhance our ability to provide secure, reliable, and innovative health monitoring solutions to women via the Incora earring and app, ensuring their data is protected and their health insights are precise.”

David Stefanich, CEO and Founder of Rymedi, expressed his enthusiasm by saying  “this partnership continues our mission to help life science organizations improve human health.  We are excited to bringWeb3 and DeSci solutions to the global diagnostic testing device market.”

*********************

About Incora Health

Incora Health is dedicated to empowering women with valuable insights to manage their overall health based on their unique menstrual cycles. Our innovative smart earring makes it convenient and stylish to track menstrual cycles and overall well-being. By effortlessly integrating cutting-edge technology and precise data into everyday life, Incora enables women to make informed and proactive health decisions to become their best selves. Incora’s smart earrings hit the market this fall. For more information and to sign up for the presale, visit www.incorahealth.com.

About Rymedi

Founded in 2018 as a blockchain-enabled software as a service (SAAS) company, Rymedi enables life science organizations to improve human health.  Rymedi’s patient and population health data management software supports clinical trials and patient registries, clinical diagnostic and toxicology testing devices, clinical lab integrations, and the secure and compliant storage of healthcare data.  Rymedi’s platform runs on three separate Avalanche blockchain subnets, providing an incredibly powerful L1 blockchain infrastructure for decentralized science.  For more information, please visit www.rymedi.com.